A 38-year-old woman with sepsis secondary to aspiration pneumonia has been intubated for 4 days and meets Berlin criteria for moderate ARDS (PaO₂/FiO₂ = 150). Her clinical course has been complicated by persistent hypoxemia despite escalating PEEP. Which investigation is most useful to assess for occult complications and guide further management?

Explanation

## Investigation of Persistent Hypoxemia in ARDS ### Clinical Problem: Why Is This Patient Not Improving? Persistent or worsening hypoxemia in ARDS despite appropriate ventilator management suggests: 1. **Ventilator-associated complications** (VAP, pneumothorax, tube malposition) 2. **Structural complications** (pleural effusion, atelectasis) 3. **Inadequate lung recruitment** (PEEP not optimized) 4. **Right ventricular dysfunction** (cor pulmonale from prolonged hypoxemia) 5. **Ongoing sepsis** (inadequate source control) ### Why Portable CXR + Ultrasound? **Key Point:** Bedside imaging (portable CXR + lung ultrasound) is the **most appropriate next investigation** because it: - **Rapidly identifies reversible complications**: pneumothorax, hemopneumothorax, large pleural effusion, tube malposition - **Assesses lung recruitment**: B-lines, consolidation, air bronchograms guide PEEP titration - **Non-invasive and repeatable**: Can be done at bedside without transport - **Guides immediate intervention**: Drainage of effusion, tube repositioning, or PEEP adjustment **High-Yield:** Lung ultrasound is superior to CXR alone for detecting: - Pneumothorax (absent lung sliding, barcode sign) - Pleural effusion (anechoic space, sinusoid sign) - Recruitment potential (dynamic air bronchograms) ### Severity Grading of Hypoxemia | Criterion | Moderate ARDS | Severe ARDS | |-----------|---------------|-------------| | PaO₂/FiO₂ | 101–200 | ≤100 | | PEEP | ≥5 cm H₂O | ≥10 cm H₂O | | Mortality | ~25–30% | ~40–50% | | Management | Lung-protective ventilation, PEEP titration | Consider prone positioning, ECMO if available | **Clinical Pearl:** In this patient, the PaO₂/FiO₂ of 150 is at the lower end of moderate ARDS. Persistent hypoxemia warrants exclusion of **reversible complications** before escalating to advanced therapies (prone positioning, ECMO). ### Why Other Investigations Are Suboptimal **Warning:** Each distractor addresses a valid concern but is not the **most appropriate next step**: - **BAL**: Indicated if VAP is suspected (fever, purulent secretions, infiltrate progression), but does not address structural complications causing hypoxemia. Culture results take 48–72 hours. - **Echocardiography**: Useful to assess RV function and estimate pulmonary pressures in refractory hypoxemia, but does NOT identify acute structural complications (pneumothorax, effusion) that require immediate drainage. - **Biomarkers (PCT, CRP)**: Reflect ongoing inflammation/infection but do NOT guide acute management of hypoxemia or identify reversible complications. **Mnemonic:** **CURE** = **C**hest imaging (CXR + **U**ltrasound) for **R**eversible complications in **E**scalating ARDS.